The genetic code of a rare form of kidney cancer, called reninoma, has been studied for the first time. In a paper, published in, researchers at the Wellcome Sanger Institute, Great Ormond Street Hospital and The Royal Free Hospital also revealed a new drug target that could serve as an alternative treatment if surgery is not recommended., and it is among the rarest of tumors in humans.
The team examined two cancer samples—from a young adult and a child—with advanced genomic techniques, known as whole genome and single nuclear sequencing. Their findings suggest that the use of existing drugs targeting this specific gene is a possible solution to treating reninoma for patients where surgery is not a viable option.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: